IPSC vs JAGX

Century Therapeutics, Inc. vs Jaguar Health, Inc. — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — IPSC scores higher on quality with 5.9/10 vs JAGX's 4.1/10. IPSC trades at $2.17 while JAGX trades at $3.22. Both analyzed daily using SEC EDGAR data across 13 institutional models.

IPSC

Biotechnology
Century Therapeutics, Inc.
Quality
5.9
out of 10
Value Trap
24
SAFE
Price
$2.17
Last close
Models
12/13
Active
VS

JAGX

Biotechnology
Jaguar Health, Inc.
Quality
4.1
out of 10
Value Trap
47
WARN
Price
$3.22
Last close
Models
5/13
Active
IPSC
2 models active
Limited to 2/13 visible models
JAGX
First Chicago sees +27.9% upside
Value Trap 47/100 — caution

IPSC vs JAGX — Fair Value Comparison

IPSC
$0$1$2$3 Price$2.17 Bayesian …$0.62 (-71.6%) Earnings …$1.16 (-49.5%)
JAGX
$0$2$3$5 Price$3.22 ML-RIV$0.66 (-90.2%) First Chi…$4.44 (+27.9%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType IPSC Fair ValueIPSC Upside JAGX Fair ValueJAGX Upside
Bayesian DCF Intrinsic $0.62 -71.6% — —
Earnings Power Value Intrinsic $1.16 -49.5% — —
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $3.38 +55.9% $4.44 +27.9%
ML-RIV Intrinsic $0.57 -73.8% $0.66 -90.2%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%

IPSC vs JAGX — Which Stock Is More Undervalued in 2026?

IPSC scores higher with a 5.9/10 quality rating vs JAGX's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do IPSC and JAGX Valuations Compare?

IPSC currently trades at $2.17 while JAGX trades at $3.22. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.

Quality of Company: IPSC vs JAGX

IPSC earns a Quality of Company score of 5.9/10 compared to JAGX's 4.1/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: IPSC vs JAGX

IPSC carries a SAFE value trap risk (24/100) while JAGX shows WARN risk (47/100). Stocks with value trap scores above 40 may appear undervalued but face deteriorating fundamentals — declining margins, rising debt, or shrinking revenue can make the apparent discount a trap.

Both in Biotechnology

Both IPSC and JAGX operate in Biotechnology, which has 566 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare IPSC vs JAGX differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

IPSC
View Full Century Therapeutics, Inc. Analysis →
JAGX
View Full Jaguar Health, Inc. Analysis →
See all Biotechnology stocks →